ESTRADIOL AND NORETHINDRONE ACETATE

ESTRADIOL AND NORETHINDRONE ACETATE was reported 379 times

ESTRADIOL AND NORETHINDRONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POST CARDIAC ARREST SYNDROME 1 0.0357
1 THYROID STIMULATING IMMUNOGLOBULIN 1 0.0323
2 POST VACCINATION SYNDROME 1 0.0323
3 KALEIDOSCOPE VISION 1 0.0312
4 FEMALE SEX HORMONE LEVEL ABNORMAL 1 0.0227
5 LIMB PROSTHESIS USER 1 0.0185
6 INTERVENTRICULAR SEPTUM RUPTURE 1 0.0179
7 FORCED EXPIRATORY VOLUME INCREASED 1 0.0169
8 AUTOPHONY 1 0.0133
9 APPLICATION SITE ECZEMA 1 0.0115
10 INTESTINAL CONGESTION 1 0.0096
11 GRIP STRENGTH 2 0.0087
12 POST VIRAL FATIGUE SYNDROME 2 0.0083
13 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
14 HYPERVITAMINOSIS 1 0.0072
15 VASCULAR FRAGILITY 1 0.0064
16 BIOPSY BREAST 2 0.0064
17 ATRIAL SEPTAL DEFECT REPAIR 1 0.0058
18 BRAIN STEM ISCHAEMIA 1 0.0056
19 BREAST LUMP REMOVAL 1 0.0044
20 TYPE V HYPERLIPIDAEMIA 2 0.0041
21 SLEEVE GASTRECTOMY 1 0.0041
22 SWOLLEN JOINT COUNT 1 0.0040
23 ENDOMETRIAL THICKENING 2 0.0036
24 IMMATURE GRANULOCYTE COUNT INCREASED 1 0.0035
25 VASCULAR DEVICE OCCLUSION 1 0.0029
26 TOOTH DEPOSIT 1 0.0029
27 MILIA 1 0.0028
28 GINGIVAL ABSCESS 2 0.0027
29 LIPID METABOLISM DISORDER 1 0.0026
30 CARDIOVASCULAR SYMPTOM 1 0.0026
31 MENOPAUSAL SYMPTOMS 6 0.0026
32 ENDOMETRIAL HYPERPLASIA 2 0.0025
33 ENDOMETRIAL DISORDER 1 0.0024
34 SCIATIC NERVE INJURY 2 0.0024
35 COVID-19 IMMUNISATION 2 0.0024
36 PORPHYRIA NON-ACUTE 1 0.0023
37 TEMPORAL LOBE EPILEPSY 1 0.0023
38 GINGIVAL BLISTER 1 0.0023
39 EYELID INFECTION 1 0.0023
40 BODY HEIGHT INCREASED 1 0.0020
41 ROOT CANAL INFECTION 1 0.0020
42 ACCIDENT AT HOME 1 0.0019
43 HEPATIC ADENOMA 1 0.0019
44 INFUSION SITE MASS 2 0.0018
45 NERVE ROOT COMPRESSION 1 0.0017
46 DEVICE MAINTENANCE ISSUE 1 0.0017
47 URETHRAL PAIN 1 0.0017
48 ANOXIC ENCEPHALOPATHY 1 0.0016
49 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
50 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
51 INJECTION SITE EXFOLIATION 1 0.0015
52 CEREBRAL CYST 1 0.0015
53 PORPHYRIA ACUTE 2 0.0014
54 SMALL FIBRE NEUROPATHY 1 0.0014
55 INDIFFERENCE 1 0.0013
56 QRS AXIS ABNORMAL 1 0.0013
57 COAGULATION TEST ABNORMAL 1 0.0013
58 BREAST CALCIFICATIONS 1 0.0013
59 SIMPLE PARTIAL SEIZURES 1 0.0012
60 BREAST OPERATION 1 0.0012
61 VACCINATION COMPLICATION 1 0.0012
62 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
63 X-RAY ABNORMAL 2 0.0011
64 TRAUMATIC INTRACRANIAL HAEMORRHAGE 1 0.0011
65 ENTEROCOLITIS INFECTIOUS 1 0.0011
66 VENOUS INJURY 1 0.0011
67 VASCULAR PAIN 1 0.0010
68 LYMPHADENECTOMY 1 0.0010
69 HEMIANOPIA 1 0.0010
70 DEEP VEIN THROMBOSIS POSTOPERATIVE 2 0.0010
71 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
72 ALLERGY TO ANIMAL 1 0.0009
73 NEUROMYOPATHY 1 0.0009
74 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
75 VULVOVAGINAL DRYNESS 3 0.0009
76 INFUSION SITE BRUISING 2 0.0009
77 HEPATIC NEOPLASM 3 0.0009
78 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1 0.0009
79 CRYPTORCHISM 1 0.0009
80 DRUG EFFECT VARIABLE 1 0.0009
81 DISLOCATION OF VERTEBRA 2 0.0009
82 FOLATE DEFICIENCY 1 0.0009
83 REFLUX GASTRITIS 1 0.0008
84 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
85 INFUSION SITE WARMTH 1 0.0008
86 POST-ACUTE COVID-19 SYNDROME 1 0.0008
87 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
88 ALLERGY TO CHEMICALS 1 0.0008
89 LUPUS VULGARIS 1 0.0008
90 APPLICATION SITE EROSION 1 0.0008
91 TUMOUR PAIN 1 0.0008
92 NEUROMYELITIS OPTICA SPECTRUM DISORDER 1 0.0007
93 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
94 MAST CELL ACTIVATION SYNDROME 1 0.0007
95 AUDITORY DISORDER 1 0.0007
96 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
97 ANKLE OPERATION 1 0.0007
98 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
99 BREAST TENDERNESS 5 0.0007
100 NON-CARDIAC CHEST PAIN 2 0.0006
101 CYSTITIS INTERSTITIAL 1 0.0006
102 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
103 FACET JOINT SYNDROME 2 0.0006
104 MUSCLE INJURY 5 0.0006
105 TYMPANIC MEMBRANE PERFORATION 1 0.0006
106 PUSTULAR PSORIASIS 2 0.0006
107 INJECTION SITE OEDEMA 1 0.0006
108 RETINITIS 1 0.0006
109 MEDICAL DEVICE REMOVAL 1 0.0006
110 PAPILLARY THYROID CANCER 1 0.0006
111 EXTREMITY NECROSIS 1 0.0006
112 OTORRHOEA 1 0.0006
113 MASTECTOMY 1 0.0006
114 VERTIGO POSITIONAL 1 0.0006
115 BREAST DISCHARGE 1 0.0006
116 INFUSION SITE DISCHARGE 1 0.0006
117 SKIN HYPOPIGMENTATION 1 0.0006
118 BREAST CYST 1 0.0006
119 APPLICATION SITE DISCOMFORT 1 0.0006
120 CAROTID ARTERY OCCLUSION 2 0.0005
121 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
122 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
123 LYMPH NODE PAIN 1 0.0005
124 RADIOTHERAPY 1 0.0005
125 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
126 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
127 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
128 BLEPHARITIS 2 0.0005
129 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
130 LIBIDO INCREASED 1 0.0005
131 PERIPHERAL VENOUS DISEASE 2 0.0005
132 INFUSION SITE SWELLING 3 0.0005
133 BREAST PAIN 5 0.0005
134 OLIGOMENORRHOEA 1 0.0005
135 DIABETIC NEPHROPATHY 1 0.0005
136 RHEUMATIC FEVER 2 0.0004
137 LICHEN PLANUS 1 0.0004
138 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
139 ROSACEA 2 0.0004
140 SINUS PAIN 1 0.0004
141 SINUS OPERATION 1 0.0004
142 PAINFUL RESPIRATION 1 0.0004
143 METRORRHAGIA 7 0.0004
144 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
145 STEM CELL TRANSPLANT 1 0.0004
146 AMMONIA INCREASED 2 0.0004
147 MENOPAUSE 1 0.0004
148 ACTINIC KERATOSIS 1 0.0004
149 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
150 ANIMAL BITE 1 0.0004
151 BLOOD POTASSIUM ABNORMAL 1 0.0004
152 EAR CONGESTION 1 0.0004
153 APPLICATION SITE HAEMORRHAGE 1 0.0004
154 TENOSYNOVITIS 1 0.0004
155 INTERMENSTRUAL BLEEDING 2 0.0004
156 ELECTRIC SHOCK SENSATION 1 0.0004
157 DRUG TOLERANCE DECREASED 1 0.0004
158 PERIORBITAL SWELLING 2 0.0004
159 SCAB 4 0.0004
160 FIBULA FRACTURE 1 0.0003
161 EYELID MARGIN CRUSTING 1 0.0003
162 HOT FLUSH 25 0.0003
163 LIP DRY 3 0.0003
164 EYELIDS PRURITUS 1 0.0003
165 SWOLLEN JOINT COUNT INCREASED 1 0.0003
166 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
167 SKIN EROSION 1 0.0003
168 BREAST CANCER STAGE III 2 0.0003
169 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2 0.0003
170 VITAMIN D DEFICIENCY 3 0.0003
171 DEAFNESS NEUROSENSORY 1 0.0003
172 INFUSION SITE HAEMORRHAGE 1 0.0003
173 WALKING AID USER 2 0.0003
174 PRODUCT FORMULATION ISSUE 2 0.0003
175 NEAR DEATH EXPERIENCE 1 0.0003
176 LYME DISEASE 1 0.0003
177 HEPATIC CYST 1 0.0003
178 BRONCHOPNEUMONIA 1 0.0003
179 CERVICAL VERTEBRAL FRACTURE 1 0.0003
180 ERYTHEMA NODOSUM 1 0.0003
181 BONE EROSION 1 0.0003
182 FIBRIN D DIMER INCREASED 1 0.0003
183 FRUSTRATION 1 0.0003
184 MONOCYTE COUNT INCREASED 1 0.0003
185 SEBORRHOEA 1 0.0003
186 DUODENAL ULCER PERFORATION 2 0.0003
187 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
188 AUTOIMMUNE THYROIDITIS 1 0.0003
189 CHEMOTHERAPY 1 0.0003
190 PARANASAL SINUS DISCOMFORT 1 0.0003
191 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
192 SKIN ODOUR ABNORMAL 1 0.0003
193 VAGINAL HAEMORRHAGE 11 0.0003
194 HYPERPHAGIA 1 0.0003
195 NIGHT SWEATS 8 0.0002
196 BURSITIS 3 0.0002
197 APPLICATION SITE EXFOLIATION 1 0.0002
198 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
199 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 1 0.0002
200 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
201 POOR PERIPHERAL CIRCULATION 1 0.0002
202 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
203 HEPATIC LESION 1 0.0002
204 IMMOBILE 1 0.0002
205 HAEMORRHAGIC ANAEMIA 1 0.0002
206 GRIP STRENGTH DECREASED 2 0.0002
207 LIGAMENT RUPTURE 1 0.0002
208 VULVOVAGINAL DISCOMFORT 1 0.0002
209 PHYSICAL DISABILITY 1 0.0002
210 BRAIN NEOPLASM MALIGNANT 1 0.0002
211 SINUS CONGESTION 3 0.0002
212 EXOSTOSIS 2 0.0002
213 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
214 NEPHROGENIC ANAEMIA 1 0.0002
215 RENAL FUNCTION TEST ABNORMAL 1 0.0002
216 UMBILICAL HERNIA 1 0.0002
217 TIBIA FRACTURE 1 0.0002
218 VAGINAL INFECTION 1 0.0002
219 BLOOD PROLACTIN INCREASED 1 0.0002
220 SEASONAL ALLERGY 3 0.0002
221 SKIN ABRASION 1 0.0002
222 MEDICATION RESIDUE PRESENT 1 0.0002
223 HYPERCHOLESTEROLAEMIA 2 0.0002
224 AUTOIMMUNE DISORDER 2 0.0002
225 COELIAC DISEASE 2 0.0002
226 BODY TEMPERATURE DECREASED 2 0.0002
227 NASAL POLYPS 1 0.0002
228 HYPERVOLAEMIA 1 0.0002
229 LIGAMENT SPRAIN 2 0.0002
230 DIABETIC NEUROPATHY 1 0.0002
231 PROTEIN URINE PRESENT 1 0.0002
232 SALIVARY HYPERSECRETION 2 0.0002
233 CORONARY ARTERY STENOSIS 1 0.0002
234 HIP ARTHROPLASTY 3 0.0002
235 EAR DISCOMFORT 2 0.0002
236 PRODUCT COLOUR ISSUE 1 0.0002
237 HELICOBACTER INFECTION 2 0.0002
238 CEREBRAL ISCHAEMIA 1 0.0002
239 BRAIN FOG 3 0.0002
240 FOLLICULITIS 2 0.0002
241 OBESITY 3 0.0002
242 SCIATICA 3 0.0002
243 BODY HEIGHT DECREASED 2 0.0002
244 IRRITABLE BOWEL SYNDROME 4 0.0002
245 BRUXISM 1 0.0002
246 GINGIVITIS 1 0.0002
247 STRESS FRACTURE 1 0.0002
248 TIC 1 0.0002
249 FAECALOMA 1 0.0002
250 FOOT DEFORMITY 2 0.0002
251 STREPTOCOCCAL INFECTION 1 0.0002
252 PERICARDITIS 3 0.0002
253 VISUAL DISTURBANCE 1 0.0002
254 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
255 RHEUMATOID FACTOR POSITIVE 1 0.0002
256 SKIN WARM 1 0.0002
257 INGUINAL HERNIA 1 0.0002
258 TENSION 1 0.0002
259 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
260 PIGMENTATION DISORDER 1 0.0002
261 MIDDLE INSOMNIA 3 0.0002
262 PEMPHIGUS 2 0.0002
263 DERMATITIS ALLERGIC 2 0.0002
264 MUSCLE ATROPHY 2 0.0002
265 GALACTORRHOEA 1 0.0002
266 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
267 PRODUCT PREPARATION ISSUE 1 0.0002
268 SOMNAMBULISM 1 0.0002
269 DYSGRAPHIA 1 0.0002
270 CORONAVIRUS INFECTION 1 0.0002
271 APPETITE DISORDER 1 0.0002
272 MENSTRUATION IRREGULAR 4 0.0001
273 JOINT RANGE OF MOTION DECREASED 2 0.0001
274 PRODUCT ADMINISTRATION ERROR 3 0.0001
275 POSTOPERATIVE WOUND INFECTION 1 0.0001
276 WRONG PRODUCT ADMINISTERED 1 0.0001
277 IMPAIRED GASTRIC EMPTYING 2 0.0001
278 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
279 APPLICATION SITE RASH 2 0.0001
280 ROAD TRAFFIC ACCIDENT 6 0.0001
281 APHONIA 2 0.0001
282 MASS 2 0.0001
283 KNEE ARTHROPLASTY 3 0.0001
284 APPLICATION SITE REACTION 1 0.0001
285 THERMAL BURN 1 0.0001
286 PRODUCT SUPPLY ISSUE 1 0.0001
287 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
288 PANIC REACTION 1 0.0001
289 VISUAL FIELD DEFECT 1 0.0001
290 HYPOKINESIA 2 0.0001
291 GASTROENTERITIS 2 0.0001
292 INTENTIONAL UNDERDOSE 1 0.0001
293 UTERINE LEIOMYOMA 1 0.0001
294 BLINDNESS TRANSIENT 1 0.0001
295 ARTHROPOD BITE 1 0.0001
296 FEELING DRUNK 1 0.0001
297 SUNBURN 1 0.0001
298 KETOACIDOSIS 1 0.0001
299 GENERAL SYMPTOM 1 0.0001
300 BLOOD POTASSIUM DECREASED 4 0.0001
301 PEMPHIGOID 1 0.0001
302 APPLICATION SITE PRURITUS 3 0.0001
303 PROCEDURAL COMPLICATION 1 0.0001
304 FOOD ALLERGY 1 0.0001
305 TENDONITIS 2 0.0001
306 BLOOD CHOLESTEROL INCREASED 6 0.0001
307 PULMONARY HAEMORRHAGE 1 0.0001
308 MULTIPLE ALLERGIES 1 0.0001
309 AFFECTIVE DISORDER 1 0.0001
310 FURUNCLE 1 0.0001
311 RENAL CYST 1 0.0001
312 FIBROMYALGIA 3 0.0001
313 CEREBRAL INFARCTION 3 0.0001
314 EMBOLISM 1 0.0001
315 BLOOD UREA INCREASED 2 0.0001
316 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
317 INFUSION SITE ERYTHEMA 1 0.0001
318 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
319 INADEQUATE ANALGESIA 1 0.0001
320 SINUSITIS 12 0.0001
321 VITAMIN D DECREASED 1 0.0001
322 BLOOD MAGNESIUM DECREASED 1 0.0001
323 PSYCHOLOGICAL TRAUMA 1 0.0001
324 CARDIAC MURMUR 1 0.0001
325 HYSTERECTOMY 1 0.0001
326 MIGRAINE 11 0.0001
327 SKIN SWELLING 1 0.0001
328 APPLICATION SITE ERYTHEMA 3 0.0001
329 RASH MACULAR 4 0.0001
330 SPINAL OSTEOARTHRITIS 1 0.0001
331 EAR INFECTION 3 0.0001
332 HAEMARTHROSIS 1 0.0001
333 GASTROINTESTINAL INFECTION 1 0.0001
334 MOBILITY DECREASED 8 0.0001
335 OROPHARYNGEAL DISCOMFORT 1 0.0001
336 TOOTHACHE 2 0.0001
337 OPTIC NEURITIS 1 0.0001
338 RESTLESS LEGS SYNDROME 2 0.0001
339 END STAGE RENAL DISEASE 2 0.0001
340 SKIN LESION 3 0.0001
341 NERVE COMPRESSION 1 0.0001
342 BREAST CANCER STAGE I 1 0.0001
343 CONJUNCTIVITIS 2 0.0001
344 FEELING COLD 3 0.0001
345 BREAST CANCER 10 0.0001
346 DEFORMITY 1 0.0001
347 BLISTER 6 0.0001
348 HEPATIC CIRRHOSIS 2 0.0001
349 FOOT FRACTURE 2 0.0001
350 PRODUCT PACKAGING ISSUE 1 0.0001
351 GASTRIC ULCER 2 0.0001
352 PULMONARY FIBROSIS 2 0.0001
353 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
354 PRODUCT SUBSTITUTION ISSUE 6 0.0001
355 LOWER LIMB FRACTURE 2 0.0001
356 ATELECTASIS 1 0.0001
357 ORAL HERPES 2 0.0001
358 SKIN FISSURES 2 0.0001
359 MENORRHAGIA 2 0.0001
360 VITREOUS FLOATERS 1 0.0001
361 THERAPY CHANGE 1 0.0001
362 LABORATORY TEST ABNORMAL 3 0.0001
363 DISABILITY 2 0.0001
364 INABILITY TO AFFORD MEDICATION 1 0.0001
365 DRY THROAT 1 0.0001
366 INJECTION SITE RASH 3 0.0001
367 NEUTROPHIL COUNT INCREASED 1 0.0001
368 SKELETAL INJURY 1 0.0001
369 POOR VENOUS ACCESS 1 0.0001
370 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
371 DERMATITIS ATOPIC 5 0.0001
372 SCRATCH 1 0.0001
373 BRONCHITIS 7 0.0001
374 FULL BLOOD COUNT ABNORMAL 1 0.0001
375 OSTEOARTHRITIS 4 0.0001
376 JOINT INJURY 2 0.0001
377 IMPAIRED WORK ABILITY 2 0.0001
378 SKIN LACERATION 1 0.0001
379 WOUND INFECTION 1 0.0001
380 GASTROINTESTINAL PAIN 1 0.0001
381 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
382 VIRAL INFECTION 3 0.0001
383 GLOSSODYNIA 2 0.0001
384 EYE PRURITUS 3 0.0001
385 SNEEZING 2 0.0001
386 SKIN INFECTION 1 0.0001
387 INTESTINAL PERFORATION 1 0.0001
388 BLOOD CALCIUM DECREASED 1 0.0001
389 DERMATITIS CONTACT 1 0.0001
390 ILLNESS 9 0.0001
391 MYOCARDITIS 1 0.0001
392 MADAROSIS 1 0.0001
393 EYELID OEDEMA 1 0.0001
394 INJURY 6 0.0001
395 SPINAL PAIN 1 0.0001
396 SURGERY 5 0.0001
397 LYMPHADENOPATHY 3 0.0001
398 BLOOD IRON DECREASED 1 0.0001
399 DISEASE RECURRENCE 4 0.0001
400 PRODUCTIVE COUGH 4 0.0001
401 FEELING HOT 5 0.0001
402 LIVER INJURY 2 0.0001
403 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
404 SPINAL OPERATION 1 0.0001
405 HYPERCALCAEMIA 1 0.0001
406 DYSGEUSIA 6 0.0001
407 APPLICATION SITE IRRITATION 1 0.0001
408 INJECTION SITE DISCOLOURATION 1 0.0001
409 ABDOMINAL PAIN LOWER 2 0.0001
410 HEPATITIS 2 0.0001
411 ROTATOR CUFF SYNDROME 1 0.0001
412 INFUSION SITE PAIN 1 0.0001
413 INFLAMMATION 4 0.0001
414 RHINORRHOEA 5 0.0001
415 DIPLOPIA 2 0.0001
416 ABDOMINAL DISTENSION 8 0.0001
417 MUSCULOSKELETAL PAIN 4 0.0001
418 ARTHRITIS 6 0.0001
419 HAND DEFORMITY 1 0.0001
420 TOOTH INFECTION 1 0.0001
421 SARS-COV-2 TEST POSITIVE 1 0.0001
422 DYSMENORRHOEA 1 0.0001
423 ADVERSE REACTION 1 0.0001
424 FREQUENT BOWEL MOVEMENTS 2 0.0001
425 THROAT TIGHTNESS 2 0.0001
426 PSORIATIC ARTHROPATHY 3 0.0001
427 COORDINATION ABNORMAL 1 0.0001
428 CARPAL TUNNEL SYNDROME 1 0.0001
429 BLOOD TEST ABNORMAL 1 0.0001
430 DYSPEPSIA 7 0.0001
431 BLINDNESS UNILATERAL 1 0.0001
432 EYE PAIN 4 0.0001
433 SINUS TACHYCARDIA 1 0.0001
434 DEPRESSION 16 0.0001
435 BRONCHOSPASM 1 0.0001
436 THERAPY INTERRUPTED 5 0.0001
437 PARALYSIS 1 0.0001
438 ANGINA PECTORIS 2 0.0001
439 IMPAIRED QUALITY OF LIFE 1 0.0001
440 INJECTION SITE HAEMATOMA 1 0.0001
441 PALPITATIONS 8 0.0001
442 PAIN IN EXTREMITY 20 0.0001
443 PSYCHOTIC DISORDER 2 0.0001
444 RENAL INJURY 2 0.0001
445 PULMONARY MASS 1 0.0001
446 HYPOAESTHESIA 10 0.0001
447 ECONOMIC PROBLEM 1 0.0001
448 VERTIGO 4 0.0001
449 DISCOMFORT 4 0.0001
450 INSURANCE ISSUE 1 0.0001
451 MUSCLE SPASMS 12 0.0001
452 EMOTIONAL DISORDER 2 0.0001
453 FEMUR FRACTURE 2 0.0001
454 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
455 ULCER 1 0.0001
456 COVID-19 11 0.0001
457 CONTUSION 6 0.0001
458 MUSCLE TIGHTNESS 1 0.0001
459 SWELLING FACE 4 0.0001
460 PRODUCT DOSE OMISSION 4 0.0001
461 LUNG DISORDER 3 0.0001
462 IMPAIRED HEALING 2 0.0001
463 PHOTOSENSITIVITY REACTION 1 0.0001
464 DRY EYE 3 0.0001
465 FUNGAL INFECTION 2 0.0001
466 URINARY RETENTION 2 0.0001
467 TYPE 2 DIABETES MELLITUS 2 0.0001
468 FLUID RETENTION 3 0.0001
469 PRODUCT QUALITY ISSUE 8 0.0001
470 SCAR 1 0.0001
471 MUSCULOSKELETAL DISCOMFORT 1 0.0001
472 JOINT SWELLING 7 0.0001
473 BALANCE DISORDER 5 0.0001
474 NIGHTMARE 2 0.0001
475 DELIRIUM 2 0.0001
476 NERVOUSNESS 3 0.0001
477 HAEMORRHAGE 6 0.0001
478 SPEECH DISORDER 3 0.0001
479 SYRINGE ISSUE 1 0.0001
480 MUSCULOSKELETAL STIFFNESS 5 0.0001
481 BURNING SENSATION 4 0.0001
482 HEART RATE DECREASED 2 0.0001
483 SLEEP DISORDER 4 0.0001
484 VISUAL IMPAIRMENT 7 0.0001
485 TACHYCARDIA 5 0.0001
486 ANXIETY 16 0.0001
487 GALLBLADDER DISORDER 1 0.0001
488 DRUG EFFECT DECREASED 3 0.0001
489 SYNOVITIS 1 0.0001
490 OSTEOMYELITIS 1 0.0001
491 HYPERGLYCAEMIA 2 0.0001
492 BONE DISORDER 1 0.0001
493 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
494 INJECTION SITE MASS 2 0.0001
495 ARTHROPATHY 3 0.0001
496 NECK PAIN 3 0.0001
497 WEIGHT INCREASED 12 0.0001
498 SWELLING 5 0.0001
499 PHOTOPHOBIA 1 0.0001
500 BLOOD SODIUM DECREASED 1 0.0001
501 COLITIS 2 0.0001
502 BLOOD URINE PRESENT 1 0.0001
503 SLEEP APNOEA SYNDROME 1 0.0001
504 EYE IRRITATION 3 0.0001
505 PRESCRIBED OVERDOSE 1 0.0001
506 PLASMA CELL MYELOMA 2 0.0001
507 KIDNEY INFECTION 1 0.0001
508 ALOPECIA 10 0.0001
509 INJECTION SITE BRUISING 4 0.0001
510 PREGNANCY 1 0.0000
511 IRRITABILITY 3 0.0000
512 FULL BLOOD COUNT DECREASED 1 0.0000
513 STOMATITIS 3 0.0000
514 DRY MOUTH 4 0.0000
515 BLINDNESS 2 0.0000
516 INSOMNIA 13 0.0000
517 PRODUCT PREPARATION ERROR 1 0.0000
518 OSTEOPOROSIS 2 0.0000
519 HYPERSENSITIVITY 9 0.0000
520 PULMONARY HYPERTENSION 1 0.0000
521 DERMATITIS 1 0.0000
522 MYALGIA 8 0.0000
523 RETCHING 1 0.0000
524 RECTAL HAEMORRHAGE 2 0.0000
525 FAECES DISCOLOURED 1 0.0000
526 AMNESIA 3 0.0000
527 PRODUCT DISPENSING ERROR 1 0.0000
528 BLOOD PRESSURE INCREASED 7 0.0000
529 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
530 MELAENA 1 0.0000
531 INFUSION RELATED REACTION 3 0.0000
532 ANGIOEDEMA 2 0.0000
533 BLOOD PRESSURE DECREASED 3 0.0000
534 LIVER DISORDER 2 0.0000
535 INFLUENZA 5 0.0000
536 COLITIS ULCERATIVE 2 0.0000
537 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
538 THROAT IRRITATION 2 0.0000
539 PARAESTHESIA 7 0.0000
540 THERAPY NON-RESPONDER 2 0.0000
541 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
542 ASTHMA 5 0.0000
543 RHEUMATOID ARTHRITIS 5 0.0000
544 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
545 PRODUCT AVAILABILITY ISSUE 1 0.0000
546 ERYTHEMA 9 0.0000
547 ABDOMINAL PAIN UPPER 9 0.0000
548 TINNITUS 2 0.0000
549 ADVERSE EVENT 4 0.0000
550 NASOPHARYNGITIS 8 0.0000
551 MUSCLE TWITCHING 1 0.0000
552 ARTHRALGIA 18 0.0000
553 OROPHARYNGEAL PAIN 4 0.0000
554 CONDITION AGGRAVATED 13 0.0000
555 HYPERTENSION 9 0.0000
556 RASH ERYTHEMATOUS 2 0.0000
557 GAIT DISTURBANCE 8 0.0000
558 PRURITUS 16 0.0000
559 DIABETIC KETOACIDOSIS 1 0.0000
560 LOCALISED INFECTION 1 0.0000
561 MENTAL IMPAIRMENT 1 0.0000
562 NEURALGIA 1 0.0000
563 ATRIAL FIBRILLATION 4 0.0000
564 PRODUCT DOSE OMISSION ISSUE 12 0.0000
565 INJECTION SITE URTICARIA 1 0.0000
566 ENCEPHALOPATHY 1 0.0000
567 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
568 MYOCARDIAL INFARCTION 7 0.0000
569 HEADACHE 25 0.0000
570 UNEVALUABLE EVENT 3 0.0000
571 ACNE 3 0.0000
572 HAEMATEMESIS 1 0.0000
573 INCORRECT DOSE ADMINISTERED 9 0.0000
574 CARDIOVASCULAR DISORDER 1 0.0000
575 CHEST DISCOMFORT 4 0.0000
576 PERIPHERAL SWELLING 6 0.0000
577 HYPERHIDROSIS 5 0.0000
578 BACK PAIN 9 0.0000
579 RESPIRATORY TRACT INFECTION 1 0.0000
580 PSORIASIS 5 0.0000
581 DEAFNESS 1 0.0000
582 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
583 GASTRITIS 1 0.0000
584 DEPRESSED MOOD 2 0.0000
585 CHEST PAIN 7 0.0000
586 DRY SKIN 5 0.0000
587 RASH PRURITIC 2 0.0000
588 OEDEMA 2 0.0000
589 LIMB INJURY 1 0.0000
590 INFLUENZA LIKE ILLNESS 3 0.0000
591 MEMORY IMPAIRMENT 5 0.0000
592 ABNORMAL DREAMS 1 0.0000
593 DIVERTICULITIS 1 0.0000
594 PROCEDURAL PAIN 1 0.0000
595 WOUND 1 0.0000
596 ABDOMINAL DISCOMFORT 6 0.0000
597 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
598 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
599 PAIN IN JAW 1 0.0000
600 URINARY TRACT INFECTION 6 0.0000
601 INTENTIONAL DOSE OMISSION 1 0.0000
602 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
603 RED BLOOD CELL COUNT DECREASED 1 0.0000
604 SOMNOLENCE 7 0.0000
605 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
606 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
607 INFECTION 5 0.0000
608 RASH 15 0.0000
609 LIVER FUNCTION TEST ABNORMAL 1 0.0000
610 NEEDLE ISSUE 1 0.0000
611 BONE PAIN 2 0.0000
612 NASAL CONGESTION 2 0.0000
613 URINARY INCONTINENCE 1 0.0000
614 WHEEZING 2 0.0000
615 GASTROINTESTINAL DISORDER 3 0.0000
616 ADVERSE DRUG REACTION 3 0.0000
617 FATIGUE 26 0.0000
618 APHASIA 1 0.0000
619 LACRIMATION INCREASED 1 0.0000
620 THERAPEUTIC RESPONSE DECREASED 2 0.0000
621 ILL-DEFINED DISORDER 2 0.0000
622 EPILEPSY 1 0.0000
623 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
624 LIMB DISCOMFORT 1 0.0000
625 INJECTION SITE ERYTHEMA 4 0.0000
626 CONSTIPATION 7 0.0000
627 COUGH 9 0.0000
628 DIZZINESS 16 0.0000
629 HEAD INJURY 1 0.0000
630 NEUROPATHY PERIPHERAL 3 0.0000
631 CYSTITIS 1 0.0000
632 MOOD SWINGS 1 0.0000
633 HYPOTHYROIDISM 1 0.0000
634 LOSS OF CONSCIOUSNESS 4 0.0000
635 MOVEMENT DISORDER 1 0.0000
636 HIP FRACTURE 1 0.0000
637 DRUG INTOLERANCE 3 0.0000
638 BLOOD CREATININE INCREASED 2 0.0000
639 NAUSEA 24 0.0000
640 STAPHYLOCOCCAL INFECTION 1 0.0000
641 HEART RATE INCREASED 3 0.0000
642 RENAL FAILURE 4 0.0000
643 LIP SWELLING 1 0.0000
644 SKIN DISORDER 1 0.0000
645 GAIT INABILITY 1 0.0000
646 INJECTION SITE PRURITUS 2 0.0000
647 URTICARIA 5 0.0000
648 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
649 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
650 HEPATIC ENZYME INCREASED 2 0.0000
651 ASTHENIA 11 0.0000
652 FEELING ABNORMAL 7 0.0000
653 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
654 VISION BLURRED 4 0.0000
655 WEIGHT DECREASED 8 0.0000
656 HYPOXIA 1 0.0000
657 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
658 PRODUCT ADHESION ISSUE 1 0.0000
659 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
660 PAIN 17 0.0000
661 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
662 PANIC ATTACK 1 0.0000
663 RESPIRATORY FAILURE 2 0.0000
664 UNDERDOSE 2 0.0000
665 ACCIDENTAL OVERDOSE 1 0.0000
666 DRUG INEFFECTIVE 36 0.0000
667 AGITATION 2 0.0000
668 DYSURIA 1 0.0000
669 HEPATIC FUNCTION ABNORMAL 1 0.0000
670 EPISTAXIS 2 0.0000
671 DYSARTHRIA 1 0.0000
672 DYSPNOEA EXERTIONAL 1 0.0000
673 DYSPNOEA 15 0.0000
674 MUSCULAR WEAKNESS 3 0.0000
675 INJECTION SITE SWELLING 2 0.0000
676 ABDOMINAL PAIN 6 0.0000
677 DISORIENTATION 1 0.0000
678 DRUG INTERACTION 4 0.0000
679 PNEUMONIA 8 0.0000
680 EXTRA DOSE ADMINISTERED 1 0.0000
681 OEDEMA PERIPHERAL 3 0.0000
682 TREATMENT FAILURE 2 0.0000
683 RHABDOMYOLYSIS 1 0.0000
684 RENAL IMPAIRMENT 2 0.0000
685 SKIN EXFOLIATION 2 0.0000
686 CEREBROVASCULAR ACCIDENT 4 0.0000
687 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
688 INJECTION SITE PAIN 7 0.0000
689 DEVICE ISSUE 2 0.0000
690 SUICIDAL IDEATION 2 0.0000
691 DIARRHOEA 14 0.0000
692 HYPOKALAEMIA 1 0.0000
693 OCULAR HYPERAEMIA 1 0.0000
694 DYSPHAGIA 2 0.0000
695 COMA 1 0.0000
696 BLOOD GLUCOSE DECREASED 1 0.0000
697 HYPOGLYCAEMIA 1 0.0000
698 MALAISE 9 0.0000
699 SYNCOPE 2 0.0000
700 CELLULITIS 1 0.0000
701 FLUSHING 2 0.0000
702 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
703 ECZEMA 1 0.0000
704 PANCREATITIS 1 0.0000
705 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
706 PLATELET COUNT DECREASED 2 0.0000
707 CONFUSIONAL STATE 3 0.0000
708 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
709 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
710 HAEMATOCHEZIA 1 0.0000
711 ANAPHYLACTIC REACTION 1 0.0000
712 TREMOR 3 0.0000
713 OXYGEN SATURATION DECREASED 1 0.0000
714 SEIZURE 2 0.0000
715 DYSPHONIA 1 0.0000
716 CATARACT 1 0.0000
717 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
718 ANAEMIA 3 0.0000
719 DEEP VEIN THROMBOSIS 1 0.0000
720 FALL 5 0.0000
721 NEOPLASM MALIGNANT 1 0.0000
722 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
723 INJECTION SITE REACTION 1 0.0000
724 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
725 SKIN BURNING SENSATION 1 0.0000
726 HALLUCINATION 1 0.0000
727 CHRONIC KIDNEY DISEASE 1 0.0000
728 ACUTE KIDNEY INJURY 2 0.0000
729 DRUG DOSE OMISSION BY DEVICE 1 0.0000
730 VOMITING 6 0.0000
731 OFF LABEL USE 11 0.0000
732 INJECTION SITE HAEMORRHAGE 1 0.0000
733 CARDIAC FAILURE CONGESTIVE 1 0.0000
734 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
735 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
736 PRODUCT STORAGE ERROR 1 0.0000
737 INTENTIONAL PRODUCT MISUSE 1 0.0000
738 DRUG WITHDRAWAL SYNDROME 1 0.0000
739 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
740 CARDIAC DISORDER 1 0.0000
741 PRODUCT USE ISSUE 2 0.0000
742 PULMONARY EMBOLISM 1 0.0000
743 HYPOTENSION 2 0.0000
744 SEPSIS 1 0.0000
745 DECREASED APPETITE 2 0.0000
746 CHILLS 1 0.0000
747 DISEASE PROGRESSION 1 0.0000
748 EMOTIONAL DISTRESS 1 0.0000
749 DEHYDRATION 1 0.0000
750 PYREXIA 2 0.0000
751 NO ADVERSE EVENT 1 0.0000
752 BLOOD GLUCOSE INCREASED 1 0.0000
753 OVERDOSE 1 0.0000
754 DEATH 2 0.0000